These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21652240)
1. Pharmacokinetics of mirtazapine and its main metabolites in Beagle dogs: a pilot study. Giorgi M; Yun H Vet J; 2012 May; 192(2):239-41. PubMed ID: 21652240 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mirtazapine from orally administered tablets: influence of a high-fat meal. Cohen M; Panagides J; Timmer CJ; Huisman JA Eur J Drug Metab Pharmacokinet; 1997; 22(2):103-10. PubMed ID: 9248777 [TBL] [Abstract][Full Text] [Related]
3. Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects. Sitsen JM; Maris FA; Timmer CJ Eur J Clin Pharmacol; 2000 Aug; 56(5):389-94. PubMed ID: 11009047 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma. Maris FA; Dingler E; Niehues S J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):309-16. PubMed ID: 10052704 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of mirtazapine and its metabolite desmethylmirtazapine by HPLC with fluorescence detection. Meineke I; Kress I; Poser W; Rüther E; Brockmöller J Ther Drug Monit; 2004 Jun; 26(3):277-83. PubMed ID: 15167628 [TBL] [Abstract][Full Text] [Related]
7. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Ranjan OP; Shavi GV; Nayak UY; Arumugam K; Averineni RK; Meka SR; Sureshwar P Arch Pharm Res; 2011 Nov; 34(11):1919-29. PubMed ID: 22139691 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic analysis of mirtazapine. Grasmäder K; Verwohlt PL; Kühn KU; Dragicevic A; von Widdern O; Zobel A; Hiemke C; Rietschel M; Maier W; Jaehde U; Rao ML Eur J Clin Pharmacol; 2004 Sep; 60(7):473-80. PubMed ID: 15289959 [TBL] [Abstract][Full Text] [Related]
9. Determination of mirtazapine in human plasma by liquid chromatography. Ptácek P; Klíma J; Macek J J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 794(2):323-8. PubMed ID: 12954383 [TBL] [Abstract][Full Text] [Related]
10. The clinical relevance of preclinical data: mirtazapine, a model compound. Delbressine LP; Vos RM J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():29S-33S. PubMed ID: 9090575 [TBL] [Abstract][Full Text] [Related]
11. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects. Spaans E; van den Heuvel MW; Schnabel PG; Peeters PA; Chin-Kon-Sung UG; Colbers EP; Sitsen JM Eur J Clin Pharmacol; 2002 Sep; 58(6):423-9. PubMed ID: 12242602 [TBL] [Abstract][Full Text] [Related]
12. Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects. Sennef C; Timmer CJ; Sitsen JM Hum Psychopharmacol; 2003 Mar; 18(2):91-101. PubMed ID: 12590402 [TBL] [Abstract][Full Text] [Related]
13. Determination of mirtazapine and its demethyl metabolite in plasma by high-performance liquid chromatography with ultraviolet detection. Application to management of acute intoxication. Romiguieres T; Pehourcq F; Matoga M; Begaud B; Jarry C J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):163-8. PubMed ID: 12113982 [TBL] [Abstract][Full Text] [Related]
14. Enantioselective analysis of mirtazapine, demethylmirtazapine and 8-hydroxy mirtazapine in human urine after solid-phase microextraction. de Santana FJ; Jabor VA; Cesarino EJ; Lanchote VL; Bonato PS J Sep Sci; 2010 Feb; 33(2):268-76. PubMed ID: 20087868 [TBL] [Abstract][Full Text] [Related]
15. Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study. Reis M; Prochazka J; Sitsen A; Ahlner J; Bengtsson F Ther Drug Monit; 2005 Aug; 27(4):469-77. PubMed ID: 16044104 [TBL] [Abstract][Full Text] [Related]
16. A risk-benefit assessment of mirtazapine in the treatment of depression. Kasper S; Praschak-Rieder N; Tauscher J; Wolf R Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961 [TBL] [Abstract][Full Text] [Related]
17. Prokinetic effects of mirtazapine on gastrointestinal transit. Yin J; Song J; Lei Y; Xu X; Chen JD Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G796-801. PubMed ID: 24627566 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of mirtazapine, desmethylmirtazapine, 8-hydroxymirtazapine, and mirtazapine-N-oxide by enantioselective HPLC with fluorescence detection. Meineke I; Steinmetz H; Kirchheiner J; Brockmöller J Ther Drug Monit; 2006 Dec; 28(6):760-5. PubMed ID: 17164691 [TBL] [Abstract][Full Text] [Related]
19. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study. Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420 [TBL] [Abstract][Full Text] [Related]
20. Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations. Timmer CJ; Paanakker JE; Vrijmoed-de Vries M Pharm Res; 1997 Jan; 14(1):98-102. PubMed ID: 9034228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]